Search

Kaufman v. Baumgardner

Magistrate Judge Sherry R. Fallon of the United States District Court for the District of Delaware issued a ruling in case 26-054, Kaufman v. Baumgardner. The document references the filing of a PDF opinion. No specific holdings, monetary penalties, or compliance obligations are stated in the available navigation content.

Boehringer Ingelheim Patent for sGC Activators in Systemic Sclerosis Treatment

The USPTO granted patent US12600715B2 to Boehringer Ingelheim International GmbH covering methods for treating systemic sclerosis using soluble guanylate cyclase (sGC) activators of formula (I) or their pharmaceutically acceptable salts. The patent names Mary Ruth Flack, Julia Kaufman, and Indra Sethy-Coraci as inventors and includes 20 claims spanning therapeutic applications including respiratory, dermatological, pain, and immunological indications. This method patent provides Boehringer Ingelheim with enforceable exclusivity over the specified sGC activator treatment protocol for systemic sclerosis in the United States.

Texas AG Investigates "Sharia City" Development

Texas Attorney General Ken Paxton has launched an investigation into a proposed development in Kaufman County, referred to as a "sharia city." The investigation targets SEE Holding and Kaufman Solar LLC, with the AG issuing Requests to Examine to gather information on the development's legality and compliance with Texas laws.